Point72 Asia Singapore Pte. Ltd. Has $33,000 Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

Point72 Asia Singapore Pte. Ltd. boosted its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT) by 59.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,724 shares of the company’s stock after buying an additional 1,017 shares during the quarter. Point72 Asia Singapore Pte. Ltd.’s holdings in Cellebrite DI were worth $33,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of CLBT. Parallel Advisors LLC boosted its stake in shares of Cellebrite DI by 75.0% during the fourth quarter. Parallel Advisors LLC now owns 3,500 shares of the company’s stock valued at $30,000 after purchasing an additional 1,500 shares in the last quarter. Quarry LP acquired a new stake in shares of Cellebrite DI during the fourth quarter valued at about $36,000. Public Employees Retirement Association of Colorado acquired a new stake in shares of Cellebrite DI during the second quarter valued at about $71,000. nVerses Capital LLC acquired a new position in shares of Cellebrite DI in the second quarter worth approximately $103,000. Finally, Central Asset Investments & Management Holdings HK Ltd acquired a new position in shares of Cellebrite DI in the fourth quarter worth approximately $113,000. 45.88% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CLBT. TD Cowen lifted their price objective on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, September 23rd. Craig Hallum lifted their target price on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. JPMorgan Chase & Co. lifted their target price on Cellebrite DI from $14.00 to $15.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Lake Street Capital lifted their target price on Cellebrite DI from $13.50 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Finally, Bank of America lifted their target price on Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Eight research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI currently has an average rating of “Buy” and a consensus target price of $18.57.

Cellebrite DI Stock Down 1.9 %

NASDAQ CLBT opened at $16.52 on Wednesday. The business has a 50 day moving average price of $15.69 and a 200-day moving average price of $12.90. Cellebrite DI Ltd. has a 52 week low of $6.36 and a 52 week high of $17.82. The company has a market cap of $3.40 billion, a price-to-earnings ratio of -28.48, a P/E/G ratio of 2.32 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings results on Thursday, August 15th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.02. Cellebrite DI had a positive return on equity of 5,902.06% and a negative net margin of 28.51%. The business had revenue of $95.70 million during the quarter, compared to the consensus estimate of $91.94 million. During the same quarter in the prior year, the company posted $0.05 earnings per share. Cellebrite DI’s revenue was up 24.8% compared to the same quarter last year. On average, equities research analysts anticipate that Cellebrite DI Ltd. will post 0.31 earnings per share for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.